Zobrazeno 1 - 10
of 143
pro vyhledávání: '"André Baruchel"'
Autor:
Fanny Alby-Laurent, John Moppett, Lina Hamadeh, Arnaud Petit, André Baruchel, Vahid Asnafi, Marc R. Mansour, Elizabeth Macintyre, Rosemary E. Gale, Mary Taj, Sylvie Chevret, Ajay Vora, Anthony V. Moorman
Publikováno v:
Leukemia. 36:263-266
Autor:
Reuben Benjamin, Charlotte Graham, Deborah Yallop, Agnieszka Jozwik, Oana C Mirci-Danicar, Giovanna Lucchini, Danielle Pinner, Nitin Jain, Hagop Kantarjian, Nicolas Boissel, Marcela V Maus, Matthew J Frigault, André Baruchel, Mohamad Mohty, Athos Gianella-Borradori, Florence Binlich, Svetlana Balandraud, Fabien Vitry, Elisabeth Thomas, Anne Philippe, Sylvain Fouliard, Sandra Dupouy, Ibtissam Marchiq, Maria Almena-Carrasco, Nicolas Ferry, Sylvain Arnould, Cyril Konto, Paul Veys, Waseem Qasim, Antonio Pagliuca, Ghulam Mufti, Piers Patten, Shireen Kassam, Stephen Devereux, Majid Kazmi, Kirsty Cuthill, Victoria Potter, Andrea Kuhnl, Victoria Metaxa, Laarni Bonganay, Orla Stewart, Rose Ellard, Lorraine Catt, Jen Lewis, Farzin Farzaneh, Jackie Chappell, Alice Mason, Vicky Chu, Alan Dunlop, Adeel Saleem, Gary Cheung, Helena Munro, Elka Giemza, Oana Ciocarlie, Jan Chu, Persis Amrolia, Kanchan Rao, Robert Chiesa, Juliana Silva, Annette Hill, Maria Finch, Lindsey Young, Harvinder Hara, Sujith Samarasinghe, Anupama Rao, Ajay Vora, Kimberley Gilmour, Christine Rivat, Clare Murphy, Gulrukh Ahsan, Rasha Said Shamsah, Jesmina James, Sarah Inglott, Gary Wright, Stuart Adams, Natalia Izotova, Marina Konopleva, William Wierda, Elias Jabbour, Partow Kebrieai, Emily Jones, Kara McGee, Marcela Maus, Matthew Frigault, Jami Brown, Vesselina Toncheva, Keagan Casey, Hanno Hock, Meaghan A McKeown, Richard Mathews, Thomas Spitzer, Emmanuel Raffoux, Etienne Lengliné, Raphael Itzykson, Florence Rabian, Jérôme Larghero, Isabelle Madelaine, Elie Azoulay, Emmanuelle Clappier, Sophie Caillat-Zucman, Martine Meunier, Karine Celli-Lebras, Marie-Thérèse Tremorin, Karima Yakouben, Françoise Mechinaud-Heloury, Audrey Grain, Aurélia Alimi, Julie Roupret, Delphine Chaillou, Hélène Cavé, Aurelie Caye-Eude, Odile Fenneteau, Elodie Lainey, Jerome Naudin, Eolia Brissot, Remy Dulery, Florent Malard, Clémence Mediavilla, Agnès Bonnin, Anne Vekhoff, Tounes Ledraa, Anne Daguenel-Nguyen
Publikováno v:
The Lancet. 396:1885-1894
Summary Background Genome-edited donor-derived allogeneic anti-CD19 chimeric antigen receptor (CAR) T cells offer a novel form of CAR-T-cell product that is available for immediate clinical use, thereby broadening access and applicability. UCART19 is
Autor:
Thomas Steimlé, Marie-Emilie Dourthe, Marion Alcantara, Aurore Touzart, Mathieu Simonin, Johanna Mondesir, Ludovic Lhermitte, Jonathan Bond, Carlos Graux, Nathalie Grardel, Jean-Michel Cayuela, Isabelle Arnoux, Virginie Gandemer, Marie Balsat, Norbert Vey, Elizabeth Macintyre, Norbert Ifrah, Hervé Dombret, Arnaud Petit, André Baruchel, Philippe Ruminy, Nicolas Boissel, Vahid Asnafi
Publikováno v:
Blood Cancer Journal
Blood Cancer Journal, 2022, 12 (1), pp.14. ⟨10.1038/s41408-022-00613-9⟩
Blood Cancer Journal, Vol 12, Iss 1, Pp 1-8 (2022)
Blood Cancer Journal, 2022, 12 (1), pp.14. ⟨10.1038/s41408-022-00613-9⟩
Blood Cancer Journal, Vol 12, Iss 1, Pp 1-8 (2022)
T-cell acute lymphoblastic leukemias (T-ALL) represent 15% of pediatric and 25% of adult ALL. Since they have a particularly poor outcome in relapsed/refractory cases, identifying prognosis factors at diagnosis is crucial to adapting treatment for hi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::882a6d6080fc2fccbd51658a54c303f1
https://hal.sorbonne-universite.fr/hal-03548762
https://hal.sorbonne-universite.fr/hal-03548762
Autor:
Sara Ghorashian, Elad Jacoby, Barbara De Moerloose, Susana Rives, Denise Bonney, Geoff Shenton, Peter Bader, Nicole Bodmer, Agueda Molinos Quintana, Blanca Herrero, Mattia Algeri, Franco Locatelli, Kim Vettenranta, Berta Gonzalez, Andishe Attarbaschi, Stephen Harris, Jean Pierre Bourquin, André Baruchel
Publikováno v:
LANCET HAEMATOLOGY
[Background]: Children aged younger than 3 years were excluded from the ELIANA phase 2 trial of tisagenlecleucel in children with acute lymphoblastic leukaemia. The feasibility, safety, and activity of tisagenlecleucel have not been defined in this g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60bf81664a5944a6076fa0691f267081
https://hdl.handle.net/10807/228198
https://hdl.handle.net/10807/228198
Autor:
Arnaud Petit, Etienne Lengliné, Stéphane Ducassou, Elizabeth Macintyre, Françoise Huguet, Nicolas Boissel, Virginie Gandemer, Norbert Ifrah, Jean-Michel Cayuela, Guillaume Andrieu, Vahid Asnafi, Aline Schmidt, Nathalie Grardel, Isabelle Arnoux, Carlos Graux, Christophe Bontoux, Marie-Emilie Dourthe, Mathieu Simonin, Hervé Dombret, Ludovic Lhermitte, André Baruchel
Publikováno v:
Journal of Hematology and Oncology
Journal of Hematology and Oncology, BioMed Central, 2021, 14 (1), ⟨10.1186/s13045-021-01068-4⟩
Journal of hematology & oncology, Vol. 14, no. 1, p. 74 [1-7] (2021)
Journal of Hematology & Oncology
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-7 (2021)
Journal of Hematology and Oncology, 2021, 14 (1), ⟨10.1186/s13045-021-01068-4⟩
Journal of Hematology and Oncology, BioMed Central, 2021, 14 (1), ⟨10.1186/s13045-021-01068-4⟩
Journal of hematology & oncology, Vol. 14, no. 1, p. 74 [1-7] (2021)
Journal of Hematology & Oncology
Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-7 (2021)
Journal of Hematology and Oncology, 2021, 14 (1), ⟨10.1186/s13045-021-01068-4⟩
IDH1 and IDH2 mutations (IDH1/2Mut) are recognized as recurrent genetic alterations in acute myeloid leukemia (AML) and associated with both clinical impact and therapeutic opportunity due to the recent development of specific IDH1/2Mut inhibitors. I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74e6922d8b35993655037e3a8812c470
https://hal.sorbonne-universite.fr/hal-03218266/file/s13045-021-01068-4.pdf
https://hal.sorbonne-universite.fr/hal-03218266/file/s13045-021-01068-4.pdf
Autor:
Aline Tanguy-Schmidt, Sébastien Maury, Paola Ballerini, Nicolas Sirvent, Judith Landman-Parker, Patrice Chevallier, E. Dore, Cédric Duclos, Ibrahima Ba, Hélène Cavé, Jean Soulier, Massimiliano Bonifacio, Nicolas Duployez, Chantal Himberlin, André Baruchel, Hervé Dombret, Thorsten Braun, Ilaria Tanasi, Emmanuelle Clappier, Jerome Tamburini, Nicolas Boissel, Wendy Cuccuini, Philippe Rousselot
Publikováno v:
Blood
Blood, American Society of Hematology, 2019, 134 (16), pp.1351-1355. ⟨10.1182/blood.2019001244⟩
Blood, American Society of Hematology, 2019, 134 (16), pp.1351-1355. ⟨10.1182/blood.2019001244⟩
Tanasi et al present a prospective strategy for identifying patients with Philadelphia-like acute lymphoblastic leukemia, demonstrating the efficacy of early introduction of tyrosine kinase inhibitors in improving outcomes.
Autor:
Nicolas Boissel, Pascale Philippe-Chomette, Christelle Dufour, Benedicte Neven, Jean-Hugues Dalle, Harry Lezeau, Françoise Bernaudin, Laurence Brugières, Hélène Martelli, Sabine Sarnacki, Valérie Laurence, Annabel Paye-Jaouen, Flora Marzouk, Véronique Drouineaud, Céline Chalas, Guénolée de Lambert, Karima Yakouben, Jean Michon, Jean-Philippe Wolf, André Baruchel, Marie Prades-Borio, Dominique Valteau-Couanet, Corinne Pondarré, François Doz, Véronique Minard, Hélène Pacquement, Nathalie Dhedin, Catherine Poirot
Publikováno v:
Acta Obstetricia et Gynecologica Scandinavica. 98:630-637
Introduction The preservation of fertility is an integral part of care of children requiring gonadotoxic treatments for cancer or non-malignant diseases. In France, the cryopreservation of ovarian tissue has been considered and has been offered as a
Autor:
Julie Roupret-Serzec, Stéphanie Mathis, Nathalie Parquet, Hélène Cavé, Marie-Emilie Dourthe, Delphine Chaillou, Jean Hugues Dalle, Nathalie Dhedin, Aurélie Caye-Eude, Emmanuelle Clappier, Ilhem Rahal, Valérie Guérin-El Khourouj, Florian Chevillon, Karima Yakouben, Isabelle Madelaine, Elie Azoulay, Aurélie Cabannes-Hamy, Jérôme Larghero, Audrey Grain, Jérôme Naudin, Elodie Lainey, Francoise Mechinaud, Anne Brignier, Nicolas Boissel, Emmanuelle Lesprit, Florence Rabian, André Baruchel, Sophie Caillat-Zucman
Publikováno v:
Leukemia. 35(12)
Tisagenlecleucel therapy has shown promising efficacy for relapsed/refractory (R/R) B-cell precursor acute lymphoblastic leukemia (BCP-ALL). However, relapses occur in 30-50% of patients. Determinants for CD19pos versus CD19neg relapses are poorly ch
Autor:
Paul Bastard, Aurélien Galerne, Alain Lefevre-Utile, Coralie Briand, André Baruchel, Philippe Durand, Judith Landman-Parker, Elodie Gouache, Nathalie Boddaert, Despina Moshous, Joel Gaudelus, Robert Cohen, Georges Deschenes, Alain Fischer, Stéphane Blanche, Loïc de Pontual, Bénédicte Neven
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Frontiers in Immunology
Frontiers in Immunology, Frontiers, 2020, 11, ⟨10.3389/fimmu.2020.595478⟩
Frontiers in Immunology, 2020, 11, ⟨10.3389/fimmu.2020.595478⟩
Frontiers in Immunology
Frontiers in Immunology, Frontiers, 2020, 11, ⟨10.3389/fimmu.2020.595478⟩
Frontiers in Immunology, 2020, 11, ⟨10.3389/fimmu.2020.595478⟩
International audience; Primary infection with varicella-zoster virus (VZV) causes chickenpox, a benign and self-limited disease in healthy children. In patients with primary or acquired immunodeficiencies, primary infection can be life-threatening,
Autor:
Jean-Michel Cayuela, Nathalie Grardel, Norbert Ifrah, Carlos Graux, Elizabeth Macintyre, Marie-Emilie Dourthe, Nicolas Boissel, Virginie Gandemer, Hervé Dombret, Vahid Asnafi, Ludovic Lhermitte, Isabelle Arnoux, Arnaud Petit, André Baruchel, Etienne Lengliné, Mathieu Simonin
Publikováno v:
Blood
Blood, 2021, 137 (12), pp.1690-1694. ⟨10.1182/blood.2020007959⟩
Blood, American Society of Hematology, 2021, 137 (12), pp.1690-1694. ⟨10.1182/blood.2020007959⟩
Blood, Vol. 137, no. 12, p. 1690-1694 (2021)
Blood, 2021, 137 (12), pp.1690-1694. ⟨10.1182/blood.2020007959⟩
Blood, American Society of Hematology, 2021, 137 (12), pp.1690-1694. ⟨10.1182/blood.2020007959⟩
Blood, Vol. 137, no. 12, p. 1690-1694 (2021)
TO THE EDITOR: T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) are aggressive neoplasms that result from the proliferation of T-lymphoid progenitors blocked at thymic stages of differentiation. They account for 1